Susan DeWolf

Translational scientist who led the multimodal analyses for the CAR T-cell study, detailing single-cell RNA/TCR sequencing, cytokine profiling, and immune microenvironment remodeling observed after therapy.

Best podcasts with Susan DeWolf

Ranked by the Snipd community

Dec 25, 2025 • 24min

Novel Treatment Targets for Hemophilia A and AML

Join researcher Vincent Muczynski, who presents a groundbreaking AAV gene therapy strategy for hemophilia A using a novel bispecific antibody. He details impressive preclinical results showing promise in correcting bleeding in mice. Clinician-scientist Mark Geyer unveils his phase 1 study on CD371-targeted CAR T cells infused with interleukin-18, which shows potential in tackling relapsed/refractory acute myeloid leukemia. Translational scientist Susan DeWolf shares insights from their analyses, revealing how interleukin-18 fosters immune remodeling and enhances treatment effectiveness.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app